Talabostat April 12, 2017 Talabostat Trade Name Orphan Indication Stages IIb through IV melanoma USA Market Approval USA USA Designation Date 2017-03-20 00:00:00 Sponsor BioXcel Corporation;780 East Main Street, Suite 2;Branford, Connecticut, 06405
